Race Signs Key Manufacturing Agreement for Bisantrene
Filed with ASX · · 1 page · English
Earlier from Racura Oncology
- Race Signs NPP Partnership with CarthaGenetics in Europe
- Race signs agreement with Camargo Pharmaceutical
- Race signs agreement with Crystal Pharmatech
- Admission to Official List
Later from Racura Oncology
- Race Signs Agreement with US Based IriSys LLC
- Race Oncology Update & Investor Presentation
- Pre-IND Meeting Confirms 505(b)(2) Pathway for Bisantrene
- Bisantrene License Agreement for Korea
- Race Announces NCI Collaboration
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology